Although further studies are needed to identify the specific intracellular targets of p38, it is known that the activation of MAPKs might suppress the surviving function of Bcl-2, 38–40 and might explain why mesothelioma cells undergo Ptac2S-triggered apoptosis despite expressing high levels of Bcl-2. The gene discussed is BCL2; the disease is mesothelioma.